Janes A. Aducanumab: The Controversial New Drug Licensed to Treat Alzheimer’s Disease. TSMJ [Internet]. 2024 Mar. 14 [cited 2026 Feb. 19];22(1):6-11. Available from: https://diamondirelandpress.ie/index.php/tsmj/article/view/2811